3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
4
Renal Insufficiency
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Dexamethasone
2
melflufen
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
dabrafenib
1
belinostat
1
auricularum
1
Thalidomide
1
Pharmacogenomic Testing
1
Lenalidomide
1
L-melphalanyl-p-L-fluorophenylalanine ethyl ester
1
Cyclophosphamide
1
Calcium Dobesilate
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Renal Insufficiency
×
melflufen
×
Clear all
NCT03639610
2023-03-10
BRIDGE
Oncopeptides AB
Phase 2
Terminated
35 enrolled
33 charts